Stock · VTR · Real Estate
United States · Large Cap · listed since 1998 · Revenue 12 mo. $6.4B
Price as of 11/06/2026
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population.
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.
Original text from the data provider
Summary
41.0 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €1.2B (2025), it supports €13.1B. The remaining €28.1B of the market value assume it grows 15.9% a year for 10 years and not at all afterwards.
Required FCF growth per year
15.9%
no growth afterwards
Price to operating cash flow 23.8×, above its usual range.
Middle half of 20 quarters: 16.7× to 21.8×, median 19.0×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
No indication in the stored figures.
with respect to the priced-in expectation
Since the last quarter
Q1 → Q2 2026
3 more unchanged: EBIT margin, Net debt, Return on equity
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | 2.01% | 7.47% | Rank 15 |
| Return on capital (Greenblatt) | 3.43% | 30.55% | Rank 4 |
| EBIT margin | 14.17% | 45.85% | Rank 14 |
| FCF margin | 22.57% | 37.62% | Rank 36 |
| Gross margin | −5.90% | 55.39% | Rank 1 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 18.47% | 6.62% | Rank 80 |
| Earnings growth, 3 years per yeardoes not count towards the rank | – | 3.56% | |
| Earnings growth, 5 years per year | −14.17% | 4.17% | Rank 14 |
| Sustainable growth (ROE × retained earnings) | 6.24% | 2.49% | Rank 61 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 0.61% | 5.58% | Rank 10 |
| FCF yield | 2.87% | 4.79% | Rank 29 |
| EV/saleslower is better | 10.01 | 12.03 | Rank 67 |
| EV/EBITlower is better | 70.60 | 23.23 | Rank 4 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | 8.81% | −13.68% | Rank 87 |
| Share price, 6 months | 2.19% | −6.91% | Rank 80 |
| Share price, 3 months | 0.19% | 0.34% | Rank 47 |
| Distance from 52-week high | −11.72% | −18.73% | Rank 73 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | 4.84% | 3.12% | Rank 33 |
| Change in share countlower is better | 11.11% | 0.26% | Rank 7 |
| Dividend streak in years | 4 | 4 | Rank 63 |
| Price reaction to results, market-adjusted | −2.96% | −0.47% | Rank 15 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | 45.40% | 46.36% | Rank 47 |
| Net debt/EBITDAlower is better | 5.57 | 6.62 | Rank 61 |
| Debt to equitylower is better | 1.06 | 0.92 | Rank 40 |
| Volatility, 1 yearlower is better | 22.76% | 25.05% | Rank 62 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF | Shares | Net debt, $B |
|---|---|---|---|---|---|
| 2016 | 3.4 | 16.2% | $1.3B | 348M | 10.8 |
| 2017 | 3.6 | 17.4% | $1.3B | 359M | 11.2 |
| 2018 | 3.7 | 23.0% | $1.3B | 359M | 10.7 |
| 2019 | 3.9 | 22.2% | $877.1M | 370M | 12.3 |
| 2020 | 3.8 | 15.6% | $921.5M | 377M | 11.7 |
| 2021 | 3.8 | 11.0% | $593.1M | 386M | 12.1 |
| 2022 | 4.1 | 11.7% | $666.1M | 373M | 12.4 |
| 2023 | 4.5 | 9.2% | $935.1M | 406M | 13.2 |
| 2024 | 4.9 | 13.8% | $1.1B | 416M | 12.8 |
| 2025 | 5.8 | 14.2% | $1.3B | 463M | 12.5 |
1 of 7 StockScorer Score rules met · How the score is built
Ventas Inc mainly meets criteria in the Growth category. Result from 18 strategies checked.
This is how the StockScorer Score strategy, the flagship rule set, calculates the points for Ventas Inc. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
1 of 7 rules met
2 of 11 points
The rule “Exclusion: financial and real estate stocks” applies. The stock is therefore not rated regardless of the points scored.
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for Ventas Inc.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 163.3 | 16.4 |
| P/B ratio | 3.3 | 1.0 |
| Return on equity (ROE) | 2.0% | 7.5% |
| Equity ratio | 45.4% | 46.4% |
| Debt-to-equity (D/E) | 1.06 | 0.92 |
| Dividend yield | 2.3% | 4.2% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| VTR | Ventas Incthis page | |
| OHI | Omega Healthcare Investors Inc | locked |
| DOC | Healthpeak Properties Inc | Low5.5 |
| AHR | American Healthcare REIT, Inc. | locked |
| WELL | Welltower Inc | locked |
| VMRK | Vivmark Residential | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.